PROCTER & GAMBLE's PEPTO HEARTBURN CONTROL ENTERS TEST MARKETING
This article was originally published in The Tan Sheet
Executive Summary
PROCTER & GAMBLE's PEPTO HEARTBURN CONTROL ENTERS TEST MARKETING in Phoenix and Tucson, Ariz. the week of Nov. 7, the company announced. Pepto Heartburn Control, which does not include bismuth subsalicylate as an active ingredient, is the second "specialized" Pepto-brand product developed by P&G. Pepto Diarrhea Control, which contains loperamide, was launched at the end of 1992.